Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Reproductive decision making after the diagnosis of multiple sclerosis (MS).
The effect of intravenous immunoglobulin on neuromyelitis optica.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Setting new standards in multiple sclerosis care and research.
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.
Remyelination Therapy for Multiple Sclerosis.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Towards programming immune tolerance through geometric manipulation of phosphatidylserine.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Pages